- Home
- ABVC
ABVC
ABVC BioPharma Inc.
as 04-02-2025 4:00pm EST
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 16.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 282.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.40 - $1.73 | Next Earning Date: | 05-16-2025 |
| Revenue: | $509,788 | Revenue Growth: | -31.04% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ABVC BioPharma Inc. News
ABVC Breaking Stock News: Dive into ABVC Ticker-Specific Updates for Smart Investing
NewMediaWire
14 days ago
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
NewMediaWire
a month ago
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
NewMediaWire
a month ago
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
NewMediaWire
a month ago
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
NewMediaWire
2 months ago
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
NewMediaWire
3 months ago
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
NewMediaWire
3 months ago
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market
NewMediaWire
3 months ago
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
Compare ABVC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABVC ABVC BioPharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.